<DOC>
	<DOCNO>NCT01298310</DOCNO>
	<brief_summary>To characterize phenotype patient Morton 's neuroma explore effect local administration Xylocaine ( lidocaine )</brief_summary>
	<brief_title>A Study Characterize Phenotype Patients With Morton 's Neuroma Explore Effect Local Administration Xylocaine ( Lidocaine )</brief_title>
	<detailed_description>A randomised , double-blind , placebo-controlled , three-way cross-over single center study characterize phenotype patient Morton 's Neuroma explore effect local administration Xylocaine ( lidocaine )</detailed_description>
	<mesh_term>Neuroma</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Patients clinical diagnosis Morton 's neuroma symptom least 3 month duration one foot ( affected foot ) Visual analogue scale ( VAS ) painscore = 40 mm painful foot daily activity previous week ( visit 1 ) Allergy lidocaine Scars dermal condition foot may interfere study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Morton 's neuroma , QST measurement</keyword>
</DOC>